Profile
W Health Ventures is a venture capital firm based in India and the US, established in 2020. It is focused on building and investing in healthcare companies addressing critical unmet needs. The firm is known for its in-house team of physicians, operators, and technologists who work together to ideate, design, and derisk companies before they are fully established. This unique approach allows W Health Ventures to identify structural mismatches within the healthcare system, providing tailored solutions. They pride themselves on being thorough, committed to finding first-to-market solutions for large-scale population challenges.
The firm primarily invests in the healthcare sector with a geographical focus on the US-India corridor. They concentrate on sectors such as HealthTech, Medical Devices, AI, and more. W Health Ventures backs ventures from the pre-idea stage to becoming category leaders, providing significant operational support to accelerator companies' growth. They have raised approximately $74 million for 'Healthcare India-US Focused Fund II', with plans to invest INR 30-50 crore (around $4-6 million) per company.
Notable investments in their portfolio include Nivaan (chronic pain management), BeatO (diabetes management), ElevateNow (weight loss program), BabyMD (paediatrics), and Mylo (parenting) in India. In the US, they have invested in companies such as Wysa, offering AI mental health services, and Reveal HealthTech, providing AI transformation services. Their latest fund investments include Everhope Oncology, reimagining cancer care in India, and Everbright Health, focused on advanced depression interventions in the US.
Industry
W Health Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
W Health Ventures Fund II
|
Venture Capital (VC)
|
Healthcare Services
HealthTech
|
Pre-seed
|
North America
Asia
|
$1-5 m
|
$74 M
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.